Yüklüyor......
The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
Metastatic prostate cancer is a heterogeneous disease entity. Men without prior androgen deprivation therapy exposure are termed metastatic castration sensitive prostate cancer (mCSPC). The goal of this article is to update the reader on the rapidly changing landscape of treatment for men with mCSPC...
Kaydedildi:
| Yayımlandı: | Investig Clin Urol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Urological Association
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004830/ https://ncbi.nlm.nih.gov/pubmed/32055749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2020.61.S1.S3 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|